Patients’ and physicians’ assessment of risks associated with hypertension and benefits from treatment

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 5, Issue 3, 1998, Pages 161-166

  Kjellgren, Karin I ^a   Ahlner, John ^a   Dahlã¶f, Bjã¶rn ^b   Gill, Hans ^a   Hedner, Thomas ^b   Sã¤ljã¶, Roger ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

clinical practice; drug therapy; hypertension; risk assessment

Indexed keywords

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; RISK ASSESSMENT;

EID: 0031732288     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679800500304     Document Type: Article

References (21)

1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al Epidemiology. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
2. Kannel WB.: Potency of vascular risk factors as the basis for antihypertensive therapy Eur Heart J 1992; 13 (suppl G): 34–42.
3. Swales JD. Pharmacological treatment of hypertension. Lancet 1994; 344: 380–385.
4. Strasser T. Equal blood pressure levels carry different risks in different risk factor combinations. J Hum Hypertens 1992; 6: 261–264.
5. Strasser T.: Addressing the entire risk profile J Hum Hypertens 1990; 4 (suppl 1): 51–53.
6. Fahey TP, Peters TJ. What constitutes controlled hypertension? Patient based comparison of hypertension guidelines. BMJ 1996; 313: 93–96.
7. Adelswärd V, Sachs L. The meaning of 6.8: Numeracy and normality in heath information talks. Soc Sci Med 1996; 43: 1179–1187.
8. Niknian M, McKinlay SM, Rakowski W, Carleton RA. A comparison of perceived and objective CVD risk in a general population. Am J Public Health 1989; 79: 1653–1654.
9. Morris LA, Barofsky I. Impact of risk communication on accrual, regimen, and follow-up compliance. In: Cramer JA, Spilker B (editors): Patient compliance in medical practice and clinical trials. New York: Raven Press, Ltd; 1991. pp. 57–69.
10. Kirkwood BR. Essentials of medical statistics. Oxford: Blackwell Scientific Publications; 1994. pp. 194–197.
11. Nilsson P, Andersson DKG, Andersson P-E, Schwan Å, Östlind B, Malmborg R, et al Cardiovascular risk factors in treated hypertensives - a nationwide, cross-sectional study in Sweden. J Intern Med 1993; 233: 239–245.
12. Os I, Bratland B, Dahlöf B, Gisholt K, Syvertsen J-O, Tretli S. Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. J Hypertens 1991; 9: 1097–1104.
13. Kjellgren KI, Svensson S, Ahlner J, Säljö R. Hypertensive patients' knowledge of high blood pressure. Scand J Prim Health Care 1997; 15: 188–192.
14. Huskisson EC. Visual analogue scales. In: Melzack R. (editor): Pain measurement and assessment. New York: Raven Press; 1983. pp. 33–37.
15. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: The Framingham heart study. Am J Cardiol 1987; 60: 560–565.
16. Jackson R, Barham P, Bills J, Birch T, McLennan L, MacMahon S, et al Management of raised blood pressure in New Zealand [discussion document]. BMJ 1993; 307: 107–110.
17. Kjellgren KI, Svensson S, Ahlner J, Säljö R. Antihypertensive medication in clinical encounters. Int J Cardiol 1998; 64: 161–169.
18. Swales JD.: Management guidelines for hypertension: Is anyone taking notice? J Hum Hypertens 1995; 9 (suppl 2): S9–S13.
19. Ménard J.: Critical assessment of combination therapy development Blood Press 1993; 2 (suppl 1): 5–9.
20. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997; 349: 454–457.
21. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: The rules of halves. BMJ 1990; 300: 981–983.